Suppression_NN
of_IN
TNFalpha-mediated_JJ
NFkappaB_NN
activity_NN
by_IN
myricetin_NN
and_CC
other_JJ
flavonoids_NNS
through_IN
downregulating_VBG
the_DT
activity_NN
of_IN
IKK_NN
in_IN
ECV304_NN
cells_NNS
._.

Flavonoids_NNS
are_VBP
a_DT
group_NN
of_IN
naturally-occurring_JJ
phenolic_JJ
compounds_NNS
in_IN
the_DT
plant_NN
kingdom_NN
,_,
and_CC
many_JJ
flavonoids_NNS
are_VBP
found_VBN
with_IN
vascular_JJ
protective_JJ
properties_NNS
._.

Nevertheless_RB
how_WRB
the_DT
protective_JJ
response_NN
is_VBZ
exerted_VBN
by_IN
flavonoids_NNS
is_VBZ
not_RB
well_RB
characterized_VBN
._.

In_IN
view_NN
of_IN
the_DT
nuclear_JJ
factor-kappaB_NN
-LRB-_-LRB-
NFkappaB_NN
-RRB-_-RRB-
may_MD
play_VB
a_DT
central_JJ
role_NN
in_IN
the_DT
initiation_NN
of_IN
atherosclerosis_NN
,_,
prevention_NN
of_IN
the_DT
activation_NN
of_IN
NFkappaB_NN
represents_VBZ
an_DT
important_JJ
role_NN
in_IN
protecting_VBG
vascular_JJ
injury_NN
._.

In_IN
this_DT
study_NN
,_,
the_DT
effects_NNS
of_IN
flavonoids_NNS
on_IN
NFkappaB\/inhibitor-kappaB_NN
-LRB-_-LRB-
IkappaB_NN
-RRB-_-RRB-
system_NN
in_IN
ECV304_NN
cells_NNS
activated_VBN
with_IN
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNFalpha_NN
-RRB-_-RRB-
were_VBD
examined_VBN
._.

We_PRP
investigated_VBD
the_DT
inhibitory_JJ
action_NN
of_IN
six_CD
flavonoids_NNS
on_IN
IkappaB_NN
kinase_NN
-LRB-_-LRB-
IKK_NN
-RRB-_-RRB-
activity_NN
,_,
an_DT
enzyme_NN
recently_RB
found_VBN
to_TO
phosphorylate_VB
critical_JJ
serine_NN
residues_NNS
of_IN
IkappaB_NN
for_IN
degradation_NN
._.

Of_IN
six_CD
flavonoids_NNS
tested_VBN
,_,
myricetin_NN
was_VBD
found_VBN
to_TO
strongly_RB
inhibit_VB
IKK_NN
kinase_NN
activity_NN
,_,
and_CC
prevent_VB
the_DT
degradation_NN
of_IN
IkappaBalpha_NN
and_CC
IkappaBbeta_NN
in_IN
activated_VBN
endothelial_JJ
cells_NNS
._.

Furthermore_RB
,_,
myricetin_NN
was_VBD
also_RB
found_VBN
to_TO
inhibit_VB
NFkappaB_NN
activity_NN
correlated_VBN
with_IN
suppression_NN
of_IN
monocyte_NN
adhesion_NN
to_TO
ECV304_NN
cells_NNS
._.

Therefore_RB
we_PRP
conclude_VBP
that_IN
flavonoids_NNS
may_MD
be_VB
of_IN
therapeutic_JJ
value_NN
for_IN
vascular_JJ
disease_NN
through_IN
down_JJ
regulation_NN
of_IN
NFkappaB\/IkappaB_NN
system_NN
._.

Copyright_NN
1999_CD
Wiley-Liss_NNP
,_,
Inc_NNP
._.

